• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
topic report
Fierce 15 Hero
Biotech

Introducing Fierce Biotech's 2026 Fierce 15

What does it really mean to be a Fierce 15 biotech in 2026? This is the question we had to ask ourselves when finalizing this year’s list.
James Waldron Oct 5, 2026 7:00am
shutterstock25078614631png

There Is No Such Thing as a Typical Biotech

Brought to you by Syneos Health
Nicole Kleinstreuer NIH animal testing

How NIH’s Kleinstreuer reduces animal tests without ‘backlash’

Oct 6, 2026 8:00am
How to Choose a Biologics CDMO 4 Criteria That Matter the Most

4 Criteria for Choosing the Right Biologics CDMO

Brought to you by Rezon Bio
AstraZeneca ribbon-cutting

AZ hopes for ‘amazing things’ from Kendall Square R&D center

Oct 6, 2026 5:30am
european euros

Forbion’s ‘landmark’ €2.3B fundraise to benefit 30 biotechs

Oct 6, 2026 8:12am
More News

Nuvig halts development of lead drug for rare autoimmune disease

Oct 6, 2026 2:48pm

Mimetic’s peptide shows promise in reducing neuropathic pain

Oct 6, 2026 11:00am

ArriVent’s phase 3 lung cancer trial flops, sinking stock

Oct 6, 2026 10:51am

Fierce Biotech Fundraising Tracker '26: KymaThera & more

Oct 6, 2026 10:15am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings